•  
  •  
 

Turkish Journal of Chemistry

DOI

10.3906/kim-1602-79

Abstract

This review paper covers recent advances in the synthetic strategies for novel TPase inhibitors and their potential medicinal applications over the last few decades. A brief introduction covering the structural aspects of TPase inhibitors is also included to facilitate understanding of diverse approaches to monitor the design of new inhibitors. TPase is an essential enzyme and its inhibition is a potential target in the development of anticancer drugs.

Keywords

Thymidine phosphorylase, platelet-derived endothelial cell growth factor (PDECGF), angiogenesis, thymidine phosphorylase inhibitors, anticancer drugs, inhibitor design

First Page

1

Last Page

28

Included in

Chemistry Commons

Share

COinS